Noureddine M, Chang L, Chang L, El Ayache F, El-Ayache F, Laghlali G
Res Sq. 2025; .
PMID: 39975920
PMC: 11838721.
DOI: 10.21203/rs.3.rs-5760877/v1.
Zhu A, Chen Z, Yan Q, Jiang M, Liu X, Li Z
Nat Immunol. 2025; 26(3):459-472.
PMID: 39875584
PMC: 11876067.
DOI: 10.1038/s41590-024-02072-9.
Packer C, Jasset O, Hanniford N, Brigida S, Demidkin S, Perlis R
Front Immunol. 2025; 15:1506203.
PMID: 39845965
PMC: 11750656.
DOI: 10.3389/fimmu.2024.1506203.
Da Silva Antunes R, Fajardo-Rosas V, Yu E, Galvez R, Abawi A, Escarrega E
bioRxiv. 2025; .
PMID: 39829792
PMC: 11741356.
DOI: 10.1101/2025.01.08.631842.
Kalimuddin S, Tham C, Chan Y, Hang S, Kunasegaran K, Chia A
Nat Microbiol. 2025; 10(2):374-387.
PMID: 39794472
PMC: 11790491.
DOI: 10.1038/s41564-024-01903-7.
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.
Liu J, Wang L, Kurtesi A, Budylowski P, Potts K, Menon H
NPJ Vaccines. 2025; 10(1):4.
PMID: 39788981
PMC: 11718203.
DOI: 10.1038/s41541-025-01062-8.
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.
Ramirez S, Lopez P, Faraji F, Parikh U, Heaps A, Ritz J
JCI Insight. 2024; 9(24).
PMID: 39704169
PMC: 11665554.
DOI: 10.1172/jci.insight.186078.
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.
Toran-Monserrat P, Lamonja-Vicente N, Costa-Garrido A, Carrasco-Ribelles L, Quirant B, Boigues M
JMIR Public Health Surveill. 2024; 10:e56926.
PMID: 39648969
PMC: 11606241.
DOI: 10.2196/56926.
Beyond Suppression: Peripheral T Cell Responses to Vaccination in Inflammatory Bowel Disease Patients Undergoing Anti-Tumor-Necrosis-Factor Therapy.
Qui M, Salazar E
Vaccines (Basel). 2024; 12(11).
PMID: 39591183
PMC: 11599089.
DOI: 10.3390/vaccines12111280.
Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination.
Byrne C, Schiffer J
Front Immunol. 2024; 15:1426016.
PMID: 39575237
PMC: 11578959.
DOI: 10.3389/fimmu.2024.1426016.
Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection.
Zhao X, Li X, Zhang S, Chen J, Zhao W, Wu N
Front Immunol. 2024; 15:1477721.
PMID: 39434881
PMC: 11491401.
DOI: 10.3389/fimmu.2024.1477721.
Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohorts.
Simayi A, Chen Y, Chu J, Yu H, Zhang S, Bao C
Emerg Microbes Infect. 2024; 13(1):2412619.
PMID: 39360715
PMC: 11529888.
DOI: 10.1080/22221751.2024.2412619.
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine.
Wee E, Kempster S, Ferguson D, Hall J, Ham C, Morris S
Vaccines (Basel). 2024; 12(9).
PMID: 39339997
PMC: 11436245.
DOI: 10.3390/vaccines12090965.
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy.
Li L, Matsui Y, Prahl M, Cassidy A, Golan Y, Jigmeddagva U
NPJ Vaccines. 2024; 9(1):156.
PMID: 39191763
PMC: 11349990.
DOI: 10.1038/s41541-024-00948-3.
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19.
Fan X, Song J, Cao W, Zhou M, Yang T, Wang J
Viruses. 2024; 16(7).
PMID: 39066169
PMC: 11281491.
DOI: 10.3390/v16071006.
Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection.
Zhao X, Ji B, Shang C, Li D, Zhang S, Gu H
iScience. 2024; 27(7):110283.
PMID: 39040063
PMC: 11260851.
DOI: 10.1016/j.isci.2024.110283.
SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV.
Ruta S, Popescu C, Matei L, Grancea C, Paun A, Oprea C
Vaccines (Basel). 2024; 12(6).
PMID: 38932392
PMC: 11209143.
DOI: 10.3390/vaccines12060663.
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19.
Dallan B, Proietto D, De Laurentis M, Gallerani E, Martino M, Ghisellini S
Nat Aging. 2024; 4(8):1121-1136.
PMID: 38918602
DOI: 10.1038/s43587-024-00644-w.
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
Gray-Gaillard S, Solis S, Chen H, Monteiro C, Ciabattoni G, Samanovic M
Sci Immunol. 2024; 9(96):eadj8526.
PMID: 38905326
PMC: 11824880.
DOI: 10.1126/sciimmunol.adj8526.
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study.
Qui M, Hariharaputran S, Hang S, Zhang J, Tan C, Chong C
EBioMedicine. 2024; 105:105203.
PMID: 38896919
PMC: 11237860.
DOI: 10.1016/j.ebiom.2024.105203.